Tracked deals
6
6 tracked deals across 2020-2026.
Pharmaceuticals Buyers & Acquisitions in Florida
Buyer mix
PE-led
6 pe · 2 strategic
Top trend
Volume peaked in 2021
2 tracked deals announced in 2021.
Buyer Snapshot
Top Buyers
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| 1315 Capital | 1 | Healthcare growth equity firm providing growth capital to... | PE |
| Angelini Pharma S.p.A. | 1 | International pharmaceutical company focused on brain hea... | Strategic |
| BNP Paribas (financing support/underwriter) | 1 | Provides financing support; acts as sole global coordinat... | Mixed |
| Bessemer Investors LLC | 1 | New York‑based private investment firm focused on partner... | PE |
| Blackstone funds | 1 | Alternative asset manager participating in life sciences ... | PE |
| CDP Equity (expected minority stake via capital raise, per Reuters) | 1 | Italian state-backed investment arm expected to take a mi... | Mixed |
| New Harbor Capital | 1 | Chicago-based private equity firm investing in lower midd... | PE |
| NovaQuest Private Equity | 1 | Private equity firm focused on investments in life scienc... | PE |
| Origami Capital Partners | 1 | Provider of structured, patient and flexible private capi... | PE |
| Provepharm Life Solutions | 1 | Independent French pharmaceutical company focused on revi... | Strategic |
Acquisition Volume in Pharmaceuticals in Florida by Year
Last 5 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
-
- Buyer
- Angelini Pharma S.p.A., Blackstone funds, select international partners, CDP Equity (expected minority stake via capital raise, per Reuters), BNP Paribas (financing support/underwriter)
- Target
- Catalyst Pharmaceuticals, Inc.
- Industry
- Pharmaceuticals
- Location
- Florida, United States
- Type
- Buyout
Angelini Pharma S.p.A. has entered into a definitive agreement to acquire all outstanding shares of Catalyst Pharmaceuticals, Inc. for $31.50 per share in cash, valuing the deal at approximately $4.1 billion. The transaction marks Angelini Pharma’s entry into the United States and is expected to close in the third quarter of 2026, subject to regulatory approvals and Catalyst stockholder approval.
-
- Buyer
- 1315 Capital
- Target
- USpharma Ltd.
- Industry
- Pharmaceuticals
- Location
- Florida, United States
- Type
- Growth capital
USpharma Ltd., a Miami Lakes-based pharmaceutical development and manufacturing company, received a growth equity investment from Philadelphia-based 1315 Capital. The capital will be used to accelerate development and commercialization of USpharma’s pipeline, expand commercial reach, and scale operations at its 150,000 sq. ft. US-based GMP facility.
-
October 1, 2024
- Buyer
- New Harbor Capital, Origami Capital Partners
- Target
- LGM Pharma
- Industry
- Pharmaceuticals
- Location
- Florida, United States
- Type
- Recapitalization
New Harbor Capital completed a single-asset continuation recapitalization of LGM Pharma in partnership with Origami Capital Partners to provide growth capital and facilitate liquidity for existing investors. LGM Pharma is a CDMO and API sourcing/distribution platform with manufacturing and analytical capabilities serving pharmaceutical, biotechnology and compounding pharmacy customers across multiple U.S. facilities.
-
December 20, 2021
- Buyer
- Bessemer Investors LLC
- Target
- Pet Flavors, LLC
- Industry
- Pharmaceuticals
- Location
- Florida, United States
- Type
- Growth capital
Bessemer Investors has made a significant investment in Pet Flavors, LLC, a Melbourne, Florida-based manufacturer of pharmaceutical‑grade flavor bases and palatants for pet pharmaceuticals and nutraceuticals. Founder Mark Pieloch will remain as President while Bessemer intends to establish Pet Flavors as its platform investment in the companion animal health industry; financial terms were not disclosed.
-
January 19, 2021
- Buyer
- NovaQuest Private Equity
- Target
- CoreRx, Inc.
- Seller
- Affiliates of Signet Healthcare Partners
- Industry
- Pharmaceuticals
- Location
- Florida, United States
- Type
- Buyout
NovaQuest Private Equity acquired CoreRx, Inc., a Clearwater, Florida–based contract development and manufacturing organization (CDMO). Affiliates of Signet Healthcare Partners will retain a minority stake; Goldman Sachs Specialty Lending Group provided debt financing. NovaQuest said the investment will support continued growth and capability expansion of CoreRx's clinical and commercial CDMO services.
-
December 2, 2020
- Buyer
- Provepharm Life Solutions
- Target
- Apollo Pharmaceuticals USA Inc.
- Seller
- Apollo Pharmaceuticals USA ownership (Acharya family)
- Industry
- Pharmaceuticals
- Location
- Florida, United States
- Type
- Buyout
Provepharm Life Solutions has acquired Apollo Pharmaceuticals USA Inc., a Florida-based commercial specialist in sterile injectable products for hospitals. The acquisition strengthens Provepharm's U.S. commercial platform and adds Apollo's four registered products, enabling faster U.S. growth and streamlined hospital-focused sales operations.
Build a buyer list for your Pharmaceuticals deal
Find buyers actively acquiring pharmaceuticals companies.
Related Acquisition Pages
Pharmaceuticals Buyers & Acquisitions
Pharmaceuticals Buyers & Acquisitions in Canada
Private Equity-Backed Pharmaceuticals Buyers
Pharmaceuticals Acquisitions in 2026
Pharmaceuticals Acquisitions in 2025
Pharmaceuticals Acquisitions in 2024
Pharmaceuticals Acquisitions in 2021
Pharmaceuticals Acquisitions in 2020
Acquisitions in Florida
Private Equity-Backed Acquisitions in Florida
Acquisitions in Florida in 2026
Acquisitions in Florida in 2025